PURE Bioscience, Inc. Stock Other OTC
Equities
PURE
US74621T2096
Household Products
Financials (USD)
Sales 2022 | 1.85M | Sales 2023 | 1.88M | Capitalization | 9.51M |
---|---|---|---|---|---|
Net income 2022 | -3M | Net income 2023 | -3M | EV / Sales 2022 | 10.2 x |
Net cash position 2022 | 3.39M | Net cash position 2023 | 74K | EV / Sales 2023 | 5.03 x |
P/E ratio 2022 |
-5.08
x | P/E ratio 2023 |
-2.39
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 59.55% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 23-02-07 |
Mark Elliott
DFI | Director of Finance/CFO | 48 | 03-12-31 |
Dolana Blount
CTO | Chief Tech/Sci/R&D Officer | - | 97-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 23-02-07 |
Tom Myers
CTO | Chief Tech/Sci/R&D Officer | 71 | 11-05-08 |
Tom Lee
BRD | Director/Board Member | 75 | 14-10-23 |
1st Jan change | Capi. | |
---|---|---|
+12.44% | 26.16B | |
+2.73% | 18.31B | |
-26.63% | 6.21B | |
+6.04% | 6.02B | |
-5.67% | 3.05B | |
+5.20% | 2.45B | |
-12.14% | 1.88B | |
+27.19% | 938M | |
-4.16% | 624M |